Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2026-04-23 @ 7:47 PM
Study NCT ID:
NCT00436605
Status:
COMPLETED
Last Update Posted:
2014-05-15
First Post:
2007-02-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
NCI-2009-00219
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None